Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Market reaction to yesterday s news
View:
Post by palinc2000 on Dec 03, 2022 7:31am

Market reaction to yesterday s news

Makes no sense but obviously the sellers were those who had bought solely in expectations of positive outcome in phase 1 b...a dream that has not come true at least not for now
It will be interesting to see what comes next ...Paul probably did not have the option of not pursuing the oncology development when he joined but now if he decides to go ahead with a revised protocol he is going to own the outcome...I kind of agree with NBF 's analyst on what THTX should  concentrate on in the future .... but we dont know what we diont know!
The ball is clearly in Paul s court and the next move might very well define his legacy!!
Needs to focus on increasing value !
Comment by Bucknelly21 on Dec 03, 2022 10:32am
Still making excuses for paul? Sp has done nothing but fall since his arrival. Gets paid 2 million a year for whst exactly? So he increased sales of two niche drugs that barely bring in 80 million per year. He did a stupid offering. And has led everyone on first with nash now with cancer. The side affects are obviously not his fault but they have know this for a while and saying key to cancer only ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities